Portfolio company
Acrivon Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Celleron Therapeutics
This biopharmaceutical company develops precision medicine drugs and companion diagnostics for cancer patients to provide personalised oncology treatments.
Nuvectis Pharma
This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Accent Therapeutics
This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.
Black Diamond Therapeutics
This clinical-stage company develops precision oncology medicines and small molecule therapies for patients with genetically defined cancers.
ProteoValent Therapeutics
This company develops targeted protein degrader therapies for cancer and haematology patients.
Prometheus Biosciences
This biotechnology company develops precision medicine therapies and companion diagnostic tests for patients with inflammatory bowel disease and other immune-mediated conditions.
Profound Bio
This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.